Safety of a new transpulmonary echocontrast agent (Albunex) in repeated echocardiographic studies in patients.

MLA

Geny, B., et al. “Safety of a New Transpulmonary Echocontrast Agent (Albunex) in Repeated Echocardiographic Studies in Patients.” Clinical Cardiology, vol. 20, no. 2, Feb. 1997, pp. 111–15. EBSCOhost, https://doi.org/10.1002/clc.4960200206.

APA

Geny, B., Bischoff, P., Muan, B., Piquard, F., Thiranos, J. C., Epailly, E., Lambrechs, M., Juelsrud-Vebner, A., Eisenmann, B., & Haberey, P. (1997). Safety of a new transpulmonary echocontrast agent (Albunex) in repeated echocardiographic studies in patients. Clinical Cardiology, 20(2), 111–115. https://doi.org/10.1002/clc.4960200206

Chicago

Geny, B, P Bischoff, B Muan, F Piquard, J C Thiranos, E Epailly, M Lambrechs, A Juelsrud-Vebner, B Eisenmann, and P Haberey. 1997. “Safety of a New Transpulmonary Echocontrast Agent (Albunex) in Repeated Echocardiographic Studies in Patients.” Clinical Cardiology 20 (2): 111–15. doi:10.1002/clc.4960200206.